FRESEN.MED.CARE KGAA O.N.
FRESEN.MED.CARE KGAA O.N./ DE0005785802 /
FME
2024-03-18 11:00:23 PM
|
Chg.
-0.120
|
Volume |
Bid11:00:23 PM |
Ask11:00:23 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
34.810EUR
|
-0.34%
|
- Turnover: - |
34.810Bid Size: - |
35.010Ask Size: - |
10.26 bill.EUR |
3.20% |
15.20 |
Business description
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Management board & Supervisory board
CEO |
Helen Giza |
Management board |
Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, William Valle |
Supervisory board |
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Gregory Sorensen, MD, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon |
Company data
Name: |
Fresenius Medical Care AG & Co. KGaA |
Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
Phone: |
+49-6172-609-0 |
Fax: |
+49-6172-609-2301 |
E-mail: |
-
|
Internet: |
www.fmc-ag.de |
Industry: |
Healthcare |
Sector: |
Medical Products |
Sub sector: |
Advanced Medical Devices |
End of financial year: |
12-31 |
Free Float: |
44.95% |
IPO date: |
1996-10-02 |
Investor relations
Name: |
Dr. Dominic Heger |
IR phone: |
+49 (0) 6172 609-2525 |
IR Fax: |
+49 (0) 6172 609-2301 |
IR e-mail: |
ir@fmc-ag.com
|
Company calendar
CW 12 | 2024-03-22
4th Quarter/Annual Report
|
CW 19 | 2024-05-10
Interim Report 1st Quarter/3 Months
|
CW 20 | 2024-05-16
General Shareholder Meeting
|
CW 31 | 2024-08-02
Interim Report 2nd Quarter/6 Months
|
CW 45 | 2024-11-08
Interim Report 3rd Quarter/9 Months
|